Woods, Beth S. orcid.org/0000-0002-7669-9415, Sideris, Eleftherios, Sydes, Matthew R. et al. (41 more authors) (2018) Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE):Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. European Urology Oncology. ISSN: 2588-9311
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2018 The Authors |
| Keywords: | Cost-effectiveness analysis, Docetaxel, Prostate cancer |
| Dates: |
|
| Institution: | The University of York |
| Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
| Depositing User: | Pure (York) |
| Date Deposited: | 27 Sep 2018 15:40 |
| Last Modified: | 20 Sep 2025 00:42 |
| Published Version: | https://doi.org/10.1016/j.euo.2018.06.004 |
| Status: | Published online |
| Refereed: | Yes |
| Identification Number: | 10.1016/j.euo.2018.06.004 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:136331 |

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)